Sweden resumes use of AstraZeneca jab for seniors
Forty-three percent of melanoma patients have chronic complications from immunotherapies
25 March 2021New clues to classic cancer target found in immune cells
25 March 2021Sweden resumes use of AstraZeneca jab for seniors
Sweden’s Public Health Agency on Thursday announced it was resuming use of AstraZeneca’s COVID-19 vaccine after it was put on pause over blood clot fears, but limited it to seniors.
